Internal Medicine · Brooklyn, NY
NPI
1952403933
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
728 Ocean View Ave, Suite 1
Brooklyn, NY, 11235
Phone (718) 787-0700
Groups this clinician bills Medicare through
Medicare paid, 2024
$319K
4,463 services
Medicare patients, 2024
456
Average age 78
Drug cost, 2024
$2.0M
18,159 prescriptions
Company payments, 2025
$617
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Leonid Volfinzon was code 99213 (office e&m - established), 1,056 times for 281 patients. In total Leonid Volfinzon billed 4,463 services in 62 codes, and Medicare paid $319K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,056 | 281 | $76.94 | $81K |
| 99442 Telephone Services | Office | 880 | 264 | $74.86 | $66K |
| 36415 Venipuncture Blood Collection | Office | 493 | 250 | $4.90 | $2,416 |
| 99232 Hospital E&M - Subsequent | Facility | 264 | 103 | $68.60 | $18K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 211 | 211 | $147.22 | $31K |
| 99214 Office E&M - Established | Office | 196 | 125 | $105.89 | $21K |
| 96372 Injection Administration | Office | 129 | 27 | $12.72 | $1,641 |
| 93000 Electrocardiogram | Office | 120 | 88 | $11.87 | $1,424 |
| 93922 Duplex Scan - Extremity Arteries | Office | 108 | 108 | $70.51 | $7,615 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 105 | 104 | $172.04 | $18K |
| 95923 Electrical Nerve Conductivity | Office | 53 | 53 | $111.01 | $5,883 |
| 99238 Hospital Discharge Management | Facility | 53 | 52 | $72.25 | $3,829 |
| 95921 Electrical Nerve Conductivity | Office | 52 | 52 | $76.71 | $3,989 |
| G0008 Administration of influenza virus vaccine | Office | 48 | 47 | $29.40 | $1,411 |
| 90658 Vaccine Product | Office | 47 | 47 | $21.42 | $1,007 |
By year: 2022 $344K for 4,580 services; 2023 $360K for 4,697 services; 2024 $319K for 4,463 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 493 | 250 | $4.90 | $2,416 |
Medicare prescription drug claims, 2024
In 2024, the drug Leonid Volfinzon prescribed most often to Medicare patients was Atorvastatin Calcium, with 804 prescriptions and refills. In total Leonid Volfinzon wrote 18,159 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 804 | 1,097 | 130 | $3,796 |
| Metoprolol Succinate Generic | 763 | 995 | 112 | $5,934 |
| Amlodipine Besylate Generic | 736 | 1,027 | 128 | $1,906 |
| Losartan Potassium Generic | 708 | 898 | 105 | $3,307 |
| Rosuvastatin Calcium Generic | 610 | 836 | 96 | $3,699 |
| Metformin Hcl Generic | 416 | 609 | 70 | $1,470 |
| Diclofenac Sodium Generic | 385 | 404 | 66 | $104K |
| Omeprazole Generic | 385 | 478 | 62 | $1,755 |
| Hydrochlorothiazide Generic | 380 | 494 | 65 | $498 |
| Famotidine Generic | 321 | 376 | 44 | $1,377 |
| Hydralazine Hcl Generic | 294 | 322 | 39 | $1,103 |
| Eliquis Apixaban | 292 | 340 | 43 | $209K |
| Levothyroxine Sodium Generic | 282 | 316 | 38 | $1,068 |
| Tamsulosin Hcl Generic | 272 | 369 | 50 | $1,798 |
| Synthroid Levothyroxine Sodium | 255 | 359 | 30 | $14K |
Brand drugs: 3,289 claims; generic drugs: 14,693 claims; opioid claims: 116.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Leonid Volfinzon $617 ($617 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $198.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 9 | $198 |
| Ardelyx, Inc. ARDX | 2 | $65.74 |
| Amgen Inc. AMGN | 3 | $63.17 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $58.5 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48.76 |
| Merck Sharp & Dohme LLC MRK | 2 | $47.82 |
| Novo Nordisk Inc NVO | 1 | $28.52 |
| Amneal Pharmaceuticals LLC AMRX | 1 | $24.29 |
| GlaxoSmithKline, LLC. GSK | 1 | $22.97 |
| Kowa Pharmaceuticals America, Inc. | 1 | $22.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.